LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Molecular Biologists Define a New Role for Oxysterol Binding Proteins

By LabMedica International staff writers
Posted on 08 May 2012
A recent paper discussed the role of a specialized type of lipid transfer protein and put forward the suggestion that these proteins have little to do with intracellular cholesterol transport but instead are critically involved in the processes of membrane assembly and lipid signaling.

Oxysterols are usually defined as oxygenated derivatives of cholesterol, though plant sterols can also be oxidized, and they are important as short-lived intermediates or end products in the catabolism or excretion of cholesterol. They are normally present in biological membranes and lipoproteins at trace levels only, though they can exert profound biological effects at these concentrations. However, they are always accompanied by a great excess of cholesterol.

Oxysterol-binding protein (OSBP) and OSBP-related proteins (ORPs) constitute a large gene family that differentially localize to the membranes of cellular organelles, reflecting a functional role in sterol signaling and/or transport. OSBP activity is divided between the endoplasmic reticulum (ER) and Golgi apparatus where it imparts sterol-dependent regulation of ceramide transport and sphingomyelin synthesis.

Investigators at Simon Fraser University (Burnaby, BC, Canada) worked with the ORPs encoded by the yeast OSH gene family (OSH1–OSH7) as a model system for intracellular lipid transport. These proteins are known to transfer oxysterols in the cell, but their role in cholesterol metabolism had not been defined.

In a paper published in the March 30, 2012, issue of the Journal of Biological Chemistry the investigators revisited the proposal that Osh proteins are sterol transfer proteins and presented new models consistent with known Osh protein functions. These models focused on the role of Osh proteins as sterol-dependent regulators of phosphoinositide and sphingolipid pathways. In contrast to their posited role as nonvesicular sterol-transfer proteins, they proposed that Osh proteins coordinated lipid signaling and membrane reorganization with the assembly of tethering complexes to promote molecular exchanges at membrane contact sites.

The investigators found that cholesterol binding interfered with ORPs' ability to bind to phosphatidylinositol 4-phosphate (PI4P), which is a precursor of phosphatidylinositol (4, 5)-bisphosphate. PI4P is prevalent in the membrane of the Golgi apparatus and is important for cell growth.

“The assumption was that ORPs bind and transport cholesterol inside cells in a similar fashion to how lipoproteins bind and move around the fat outside cells through the blood stream,” said first author Dr. Chris Beh, associate professor of molecular biology and biochemistry at Simon Frazer University. "Our findings told us that ORPs probably have nothing to do with moving around cholesterol within cells. Rather cholesterol binding puts the brakes on ORP's ability to bind to PI4P, which, if left unchecked, could accelerate cell growth like crazy. Given that uncontrolled cell growth is a key feature of cancer, this means gaining a better understanding of the true purpose of cholesterol-binding within cells could be important in cancer treatment.”

Related Links:

Simon Fraser University


Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Capillary Blood Collection Tube
IMPROMINI M3
New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more